Valuation: RushNet, Inc.

Market Cap 12.26M 10.94M 10.19M 9.28M 17.47M 1.18B 17.6M 123M 47.92M 603M 46.04M 45.05M 1.94B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 16.23M 15.12M 13.76M 25.91M 1.75B 26.11M 183M 71.09M 894M 68.3M 66.82M 2.87B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 2024-03-03
Chief Operating Officer 45 2021-08-01
Director TitleAgeSince
Chairman - 2024-03-03
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 8.77K
+2.51%+0.54%+5.68%+58.35% 679B
+1.23%-2.58%-3.56%+62.21% 78.07B
-0.63%+2.91%+9.53%+155.22% 66.87B
-4.22%+0.30%+81.72%+1,127.93% 63.75B
+3.05%+0.24%-21.43%-5.34% 46.55B
+2.56%+3.98%-0.94%+78.78% 46.08B
+0.38%+3.34%+13.53%+32.69% 31.71B
+1.80%+1.39%+39.33%+59.37% 26.38B
+4.01%+0.26%-63.83%-59.22% 24.54B
Average +1.27%+0.10%+6.67%+167.77% 106.26B
Weighted average by Cap. +1.96%+0.38%+7.80%+123.54%

Financials

2020 2021
Net sales 4.39M 3.91M 3.65M 3.32M 6.25M 423M 6.3M 44.07M 17.14M 216M 16.47M 16.12M 693M 5.9M 5.26M 4.9M 4.46M 8.4M 568M 8.46M 59.22M 23.04M 290M 22.14M 21.66M 932M
Net income 991K 884K 823K 749K 1.41M 95.41M 1.42M 9.95M 3.87M 48.7M 3.72M 3.64M 157M 164K 146K 136K 124K 233K 15.75M 235K 1.64M 639K 8.04M 614K 601K 25.84M
Net Debt 5.87M 5.24M 4.88M 4.44M 8.36M 565M 8.42M 58.95M 22.94M 289M 22.04M 21.56M 927M 5.93M 5.29M 4.93M 4.48M 8.44M 571M 8.51M 59.54M 23.17M 291M 22.26M 21.78M 937M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
26-10-05 US$0.000001 0.00% 50,000
26-10-02 US$0.000001 0.00% 2,000,001
26-10-01 US$0.000001 0.00% 1,600,500
26-09-29 US$0.000001 0.00% 20,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock